Unity Biotechnology, Inc.UBXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+0.8%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+0.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 43.76% |
| 2023 | 27.43% |
| 2022 | -12.97% |
| 2021 | 42.70% |
| 2020 | -6.72% |
| 2019 | -27.85% |
| 2018 | -44.55% |
| 2017 | -114.82% |
| 2016 | 0.00% |